Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Neurology

• Publication date

  1999-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1212/WNL.52.3.541PMID 10025784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.

  1997cited by this paper
• Functional localization of the system for visuospatial attention using positron emission tomography.

  1997cited by this paper
• Deactivation of human visual cortex during involuntary ocular oscillations. A PET activation study.

  1996cited by this paper
• Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease

  1996cited by this paper
• Directional bias of initial visual exploration. A symptom of neglect in Parkinson's disease.

  1996cited by this paper
• The influence of stimulus location on the brain activation pattern in detection and orientation discrimination. A PET study of visual attention.

  1996cited by this paper
• Extraretinal modulation of cerebral blood flow in the human visual cortex: implications for saccadic suppression.

  1995cited by this paper
• Eye movements in monkeys with local dopamine depletion in the caudate nucleus. I. Deficits in spontaneous saccades

  1995cited by this paper
• Eye movements in monkeys with local dopamine depletion in the caudate nucleus. II. Deficits in voluntary saccades

  1995cited by this paper
• Visual hemineglect induced by unilateral striatal dopamine deficiency in monkeys.

  1995cited by this paper
• A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

  1995cited by this paper
• Anatomic standardization: linear scaling and nonlinear warping of functional brain images.

  1994cited by this paper
• Cortical glucose metabolism in Parkinson's disease without dementia.

  1994cited by this paper
• Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization

  1993cited by this paper
• The visual system in Parkinson's disease.

  1993cited by this paper
• Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease.

  1992cited by this paper
• Cerebral glucose metabolism in Parkinson's disease with and without dementia.

  1992cited by this paper
• A cortico-subcortical model for generation of spatially accurate sequential saccades.

  1992cited by this paper
• Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.

  1991cited by this paper
• Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268

  1990cited by this paper
• Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease

  1990cited by this paper
• Decreased dopamine in the retinas of patients with Parkinson's disease.

  1990cited by this paper
• Cerebral metabolism of parkinsonian primates 21 days after MPTP.

  1988cited by this paper
• Effect of levodopa treatment on contrast sensitivity in Parkinson's disease

  1987cited by this paper
• Alternative Approach to Single-Scan Estimation of Cerebral Glucose Metabolic Rate Using Glucose Analogs, with Particular Application to Ischemia

  1984cited by this paper
• Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method

  1984cited by this paper
• Neglect and Related Disorders

  1984cited by this paper
• Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Parkinsonism

  1967cited by this paper

• Visuospatial impairment in Parkinson's Disease: why we should keep an eye on it.

  2025cites this paper
• Radionuclide Imaging of the Neuroanatomical and Neurochemical Substrate of Cognitive Decline in Parkinson’s Disease

  2024cites this paper
• Visual Dysfunction in Parkinson’s Disease

  2023cites this paper
• Regional Metabolic Changes Influencing Three-Dimensional Perception in Parkinson’s Disease

  2022cites this paper
• Motor Asymmetry and Interocular Retinal Thickness in Parkinson's Disease.

  2021cites this paper
• Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia

  2021cites this paper
• Magnetic resonance elastography in normal pressure hydrocephalus—a scoping review

  2021cites this paper
• Effect of Alzheimer’s Disease and Lewy Body Disease on Metabolic Changes

  2021cites this paper
• Neurological Applications of Radiopharmaceuticals

  2020cites this paper
• Parkinsonian Dementias: PET Findings

  2020cites this paper
• Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: A commonality analysis

  2020cites this paper
• Shared functional neural substrates in Parkinson's disease and drug-induced parkinsonism: association with dopaminergic depletion

  2020cites this paper
• SPECT/PET Findings in Dementia with Lewy Bodies

  2020cites this paper
• Amphetamine-induced alteration to gaze parameters: A novel conceptual pathway and implications for naturalistic behavior.

  2020cites this paper
• Vision loss and hallucinations: perspectives from neurology and ophthalmology

  2020cites this paper
• The difference of mild cognitive impairment in Parkinson's disease from amnestic mild cognitive impairment: Deeper power decrement and no phase-locking in visual event-related responses.

  2019cites this paper
• Functional impact of subthalamotomy by magnetic resonance–guided focused ultrasound in Parkinson’s disease: a hybrid PET/MR study of resting-state brain metabolism

  2019cites this paper
• Cortical Thinning and Cognitive Impairment in Parkinson's Disease without Dementia

  2018cites this paper
• Perceptual Organization in Parkinson’s Disease: A Behavioral Investigation of Basal Ganglia Dysfunction

  2018cites this paper
• Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson’s disease

  2018cites this paper
• Title An Impairment of Recognizing Emotional Facial Expressions inParkinson ' s Disease

  2018cites this paper
• Mitochondria at the Base of Neuronal Innate Immunity in Alzheimer’s and Parkinson’s Diseases

  2018cites this paper
• FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease

  2018influential citation
• Color discrimination errors associate with axial motor impairments in Parkinson's Disease

  2017cites this paper
• Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson’s Disease (PD)

  2017cites this paper
• Clinical Correlation of Abnormal Findings on Magnetic Resonance Elastography in Idiopathic Normal Pressure Hydrocephalus.

  2017cites this paper
• Patterns of Longitudinal Neural Activity Linked to Different Cognitive Profiles in Parkinson's Disease

  2016cites this paper
• Accepted Manuscript Longitudinal Changes of Cortical Microstructure in Parkinson's Disease Assessed with T1 Relaxometry Longitudinal Changes of Cortical Microstructure in Parkinson's Disease Assessed with T1 Relaxometry

  2016cites this paper
• Markers of cognitive decline in PD: The case for heterogeneity.

  2016cites this paper
• Parkinsonism and Related Disorders

  2016cites this paper
• Visual dysfunction in Parkinson’s disease

  2016cites this paper
• Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease

  2016cites this paper
• Cognitive and Perceptual Impairments in Parkinson’s Disease Arising from Dysfunction of the Cortex and Basal Ganglia

  2016cites this paper
• Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease.

  2015cites this paper
• Parkinson's disease: in vivo brain metabolomics by MRS.

  2015cites this paper
• The trajectory of disturbed resting‐state cerebral function in Parkinson's disease at different Hoehn and Yahr stages

  2015cites this paper
• Wavelet Energy and Wavelet Coherence as EEG Biomarkers for the Diagnosis of Parkinson's Disease-Related Dementia and Alzheimer's Disease

  2015cites this paper
• Parkinson Dementia: PET Findings

  2014cites this paper
• Hallucinogenic mechanisms: pathological and pharmacological insights

  2014cites this paper
• Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson’s disease

  2014cites this paper
• SPECT/PET Findings in Lewy Body Dementia

  2014cites this paper
• Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.

  2014cites this paper
• Specific frequency band of amplitude low-frequency fluctuation predicts Parkinson's disease.

  2013cites this paper
• Early Diagnosis of Alzheimer's Disease and Parkinson's Disease Associated with Dementia Using Cerebral Perfusion SPECT

  2013cites this paper
• Visual Dysfunction in Parkinson’s Disease

  2013cites this paper
• Primary Visual and Visuocognitive Deficits

  2013cites this paper
• Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction

  2013cites this paper
• Parkinson's disease and vision

  2013cites this paper
• Fovea and foveation in Parkinson's disease.

  2013cites this paper
• Foveal vision is impaired in Parkinson's disease.

  2013cites this paper
• Perfusion and metabolism imaging studies in Parkinson's disease.

  2012cites this paper
• Differences of Regional Cerebral Blood Flow between Early Alzheimer's Disease and Parkinson's Disease Associated with Dementia on 99mTc-Hexamethyl Propylene Amine Oxime Perfusion Single Photon Emission Computed Tomography

  2012cites this paper
• Interocular Asymmetry of Foveal Thickness in Parkinson Disease

  2012cites this paper
• Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI

  2012cites this paper
• Molecular imaging and the neuropathologies of Parkinson's disease.

  2012cites this paper
• Regional cerebral metabolism in mouse under chronic manganese exposure: implications for manganism.

  2012cites this paper
• Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study

  2012cites this paper
• Human brain evolution: From gene discovery to phenotype discovery

  2012cites this paper
• An Impairment of Recognizing Emotional Facial Expressions in Parkinson's Disease

  2012cites this paper
• Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease.

  2012cites this paper
• PET studies in Parkinson's disease dyskinesias and dementia

  2012cites this paper
• Retinal Disturbances in Patients and Animal Models with Huntington’s, Parkinson’s and Alzheimer’s Disease

  2011cites this paper
• Placental morphology and the cellular brain in mammalianevolution

  2011cites this paper
• Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study

  2011cites this paper
• Role of brain imaging in early parkinsonism

  2011cites this paper
• A Potential Role for Glucose Transporters in the Evolution of Human Brain Size

  2011cites this paper
• Cellular signatures in the primary visual cortex of phylogeny and placentation

  2011cites this paper
• Altered directional connectivity in Parkinson's disease during performance of a visually guided task

  2011cites this paper
• Patterns of cortical thickness and surface area in early Parkinson's disease

  2011cites this paper
• Cerebral cortical areas in which thickness correlates with severity of motor deficits of Parkinson’s disease

  2011cites this paper
• Functional correlates of lower cognitive test scores in essential tremor

  2010cites this paper
• Discriminative power of different nonmotor signs in early Parkinson's disease. A case–control study

  2010cites this paper
• Effects Of Rhythmic Context on Time Perception in Individuals with Parkinson Disease

  2010cites this paper
• Current Aspects of Cognitive Neurophysiology of Parkinson Disease: An Introduction

  2010cites this paper
• Abnormal visual activation in Parkinson's disease patients

  2010cites this paper
• Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages

  2010cites this paper
• Examining Braak's hypothesis by imaging Parkinson's disease

  2010cites this paper
• Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia

  2010cites this paper
• Zaburzenia perfuzji mózgowej ocenione metodą tomografii emisyjnej pojedynczego fotonu (SPECT) u pacjentów z otępieniem z ciałami Lewy'ego, chorobą Parkinsona oraz chorobą Alzheimera

  2009cites this paper
• "Parkinson-dementia" diseases: a comparison by double tracer SPECT studies.

  2009cites this paper
• Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease

  2009cites this paper
• Technology Insight: imaging neurodegeneration in Parkinson's disease

  2008cites this paper
• PET Instrumentation and Methodology

  2008cites this paper
• Usefulness of a blood flow analyzing program 3DSRT to detect occipital hypoperfusion in dementia with Lewy bodies.

  2008cites this paper
• Positron emission tomography for brain research.

  2008cites this paper
• Parkinson's Disease, Aging, and Visual Cognition

  2008cites this paper
• Usefulness of rCBF analysis in diagnosing Parkinson’s disease: supplemental role with MIBG myocardial scintigraphy

  2008cites this paper
• Curriculum Vitae Personal Data

  2008cites this paper
• A Whole-Brain Analysis in De Novo Parkinson Disease

  2008cites this paper
• Assessment of Parkinson's disease with imaging.

  2007cites this paper
• Imaging Parkinson's disease.

  2007cites this paper
• Perfusion and Metabolism PET Studies in Parkinson's Disease

  2007cites this paper
• Striatal dopamine denervation and sensory integration for balance in middle-aged and older adults.

  2007cites this paper
• Metabolic Topography of Parkinsonism

  2007cites this paper
• Parkinson's Disease and Brain Mitochondrial Dysfunction: A Functional Phosphorus Magnetic Resonance Spectroscopy Study

  2006cites this paper
• Cognitive Deficits and Structural Brain Changes Associated with Dementia and Visual Hallucinations in Parkinson's Disease

  2006cites this paper
• Cyanide-induced parkinsonism and F-18 FDG PET/CT findings.

  2006cites this paper
• Positron Emission Tomography of Monoaminergic Vesicular Binding in Aging and Parkinson Disease

  2006cites this paper
• Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease.

  2006cites this paper
• FDG-PET study of the bilateral subthalamic nucleus stimulation effects on the regional cerebral metabolism in advanced Parkinson disease.

  2006cites this paper